Cargando...
Efficacy and Safety of Drotaverine Hydrochloride in Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Study
BACKGROUNDS/AIMS: To study the efficacy and safety of drotaverine hydrochloride (HCl) 80 mg tablet given thrice a day in the symptomatic relief of patients with irritable bowel syndrome (IBS). PATIENTS AND METHODS: The study was a multicentric, randomized, double-blind, placebo-controlled parallel g...
Gardado en:
| Publicado en: | Saudi J Gastroenterol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4271014/ https://ncbi.nlm.nih.gov/pubmed/25434320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1319-3767.145331 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|